Ziopharm Oncology reported $-9085000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 2.2B 673M
Baxter International BAX:US $ 432M 99M
Biogen BIIB:US $ 940.9M 409.4M
Bioline Rx BLRX:US -6079000 519K
Bristol Myers Squibb BMY:US $ 3197M 9M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Curis CRIS:US $ -15061000 72K
Eleven Biotherapeutics EBIO:US -835000 9.8M
Gilead Sciences GILD:US $ 2029M 868M
GlaxoSmithKline GSK:LN 1.82B 600M
Immunogen IMGN:US $ -61053000 38.2M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Intrexon XON:US $ -17414000 3.07M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Johnson & Johnson JNJ:US $ 6941M 599M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Merk MRK:US $ 5711M 652M
Novartis NOVN:VX 3.32B 176M
Pfizer PFE:US $ 12099M 2104M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Sangamo Biosciences SGMO:US $ -45734000 473K
Tg Therapeutics TGTX:US $ -66872000 26.08M
Verastem VSTM:US $ -16980000 469K
YTE INCY:US $ 260.29M 132.62M
Ziopharm Oncology ZIOP:US $ -9085000 1.23M